Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Early Phase 1
2(66.7%)
N/A
1(33.3%)
3Total
Early Phase 1(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01573390Withdrawn

Non Invasive and Non-Contact Imaging Of Tissue Oxygenation and Vascular Reactivity

Role: lead

NCT00700791Early Phase 1Terminated

Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars

Role: lead

NCT01858376Not ApplicableCompleted

Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans

Role: lead

NCT01579227Unknown

Efficacy Of Tocotrienol a Natural Vitamin E In Biopsy Wound

Role: lead

NCT00678834Early Phase 1Completed

Human Tissue Distribution of Orally Supplemented Natural Vitamin E Tocotrienol

Role: lead

All 5 trials loaded